Summary

The global laparoscopic instrument market is projected to reach USD 15.86 billion by 2031 from USD 10.74 billion in 2026, at a CAGR of 8.1% during the forecast period.

Several key factors drive the growth of the laparoscopic instruments market. One of the main factors is the upward trend toward minimally invasive surgical procedures, favored for their benefits of smaller incisions, less postoperative pain, shorter duration of hospital stays, and faster patient recoveries. At the same time, the worldwide rise in the incidence rate of colorectal cancer, obesity, and gallbladder diseases requiring laparoscopic interventions also boosts the demand. Also, improvements in imaging, energy-based devices, and robotic assistance are contributing to the enhanced precision and better outcomes for laparoscopic surgeries. Increased healthcare spending, improved surgical infrastructure in developing countries, and the rise in awareness among patients and healthcare professionals are also huge contributors to the market expansion.

By product, the laparoscopes segment is expected to account for the largest share in the laparoscopic instruments market.
The laparoscopes segment holds the largest share in the overall laparoscopic instruments market due to their crucial role in enabling clear visualization during minimally invasive procedures. Advanced, high-resolution laparoscopes are in high demand due to the growing use of laparoscopic procedures in a variety of specialties, including urology, gynecology, and general surgery. Wider use has been encouraged by innovations like flexible scopes, 3D visualization, HD and 4K imaging, and integrated camera systems, which have greatly improved surgical accuracy and patient outcomes. The market for this segment is further strengthened by the growing number of surgeries performed for chronic conditions and the regular requirement for healthcare facilities to replace or upgrade their imaging systems. They remain essential in contemporary surgical procedures due to their contribution to enhancing real-time visualization and diagnostic precision.

By application, the general surgery segment is expected to have the largest market share in the laparoscopic instruments market.
General surgery leads the laparoscopic instruments market, largely due to the broad range of procedures such as hernia repairs, appendectomies, cholecystectomies, and bowel resections, which are increasingly performed through minimally invasive methods. The rising preference for laparoscopic techniques in general surgery is fueled by advantages like smaller incisions, less postoperative pain, quicker recovery, and shorter hospital stays. The global increase in gastrointestinal conditions, gallbladder issues, and abdominal infections has also driven up the number of general surgical interventions. Furthermore, advancements in laparoscopic technology, the growing pool of trained surgeons, and favorable reimbursement policies have supported wider adoption. The versatility and frequent use of laparoscopy in general surgery firmly establish it as a major driver of market growth.

The US is projected to grow at the highest CAGR in the North America laparoscopic instruments market.
The US is anticipated to grow at the highest CAGR in the North American laparoscopic instruments market. The nation's sophisticated healthcare system, high rate of minimally invasive surgery adoption, and ongoing technological advancements are key factors in the market's growth. Laparoscopic procedures are becoming more common as a result of the rising prevalence of chronic diseases like obesity, colorectal cancer, and gastrointestinal disorders. Rapid product innovation and commercialization are also supported by significant R&D investments, the existence of significant medical device companies, and a supportive regulatory environment. Additionally, the United States enjoys the benefits of a well-established reimbursement system and a high degree of patient and healthcare professional awareness of the benefits of laparoscopic surgery.

A breakdown of the primary participants (supply-side) for the laparoscopic instruments market referred to in this report is provided below:
- By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25%
- By Designation: C-level–45%, Director Level–35%, and Others–20%
- By Region: North America -27%, Europe -25%, Asia Pacific - 30%, Latin America - 8%, Middle East & Africa -10%

Prominent players in the laparoscopic instruments market are Olympus Corporation (Japan), Karl Storz SE & Co. KG (Germany), Johnson & Johnson (USA), Fujifilm Holdings Corporation (Japan), Medtronic plc (Ireland), Stryker Corporation (USA), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (USA), Smith & Nephew plc (UK), Hoya Corporation (Japan), Schölly Fiberoptic GmbH (Germany), Victor Medical Instruments Co., Ltd. (China), Emedomed Systems GmbH (Germany), Richard Wolf GmbH (Germany), CONMED Corporation (USA), Capsovision, Inc. (USA), The Cooper Companies Inc. (USA), Teleflex Incorporated (USA), Carl Zeiss AG (Germany), Anthrex, Inc. (USA), Laborie Medical Technologies, Inc. (Canada), Myolotec Inc. (USA), Geyi Medical Instrument Co., Ltd. (China), Fortimedix Surgical B.V. (Netherlands), and Dantschke Medizintechnik GmbH & Co. KG (Germany).

Research Coverage:
The report analyzes the laparoscopic instruments market and aims at estimating the market size and future growth potential of this market based on product, application, end user, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall laparoscopic instruments market. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:
- Analysis of key drivers (Rising volume of minimally invasive surgeries (MIS), Adoption of single-use laparoscopes to prevent infectious disease, Rising prevalence of colorectal cancer), restraints (Unfavourable healthcare reforms in the US, Dearth of trained practitioners of laparoscopy, High capital investment and operational costs), opportunities (Expansion into emerging markets with growing healthcare infrastructure, Growing healthcare market in emerging economies) and challenges (Gaps in infrastructural support for laparoscopic procedures in developing countries, Regulatory hurdles and compliance complexity)
- Market Penetration: It includes extensive information on products offered by the major players in the global laparoscopic instruments market. The report includes segmentation of the market by product, application, end user, and region.
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global laparoscopic instruments market
- Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user and region.
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global laparoscopic instruments market
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, product offerings, and capacities of the major competitors in the global laparoscopic instruments market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.3 STUDY SCOPE 29
1.3.1 SEGMENTS CONSIDERED 29
1.3.2 INCLUSIONS & EXCLUSIONS 29
1.3.3 YEARS CONSIDERED 30
1.3.4 CURRENCY CONSIDERED 30
1.4 STAKEHOLDERS 31
1.5 SUMMARY OF CHANGES 31

2 EXECUTIVE SUMMARY 32
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 32
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 33
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 34
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 35
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 36

3 PREMIUM INSIGHTS 37
3.1 LAPAROSCOPIC INSTRUMENTS MARKET OVERVIEW 37
3.2 ASIA PACIFIC: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE AND COUNTRY (2025) 38
3.3 LAPAROSCOPIC INSTRUMENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES (2025) 39
3.4 LAPAROSCOPIC INSTRUMENTS MARKET, BY REGION (2024–2031) 40
3.5 LAPAROSCOPIC INSTRUMENTS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 40

4 MARKET OVERVIEW 41
4.1 INTRODUCTION 41
4.1.1 DRIVERS 42
4.1.1.1 Increasing adoption of minimally invasive surgeries over open surgeries 42
4.1.1.2 Rising adoption of single-use laparoscopic instruments 42
4.1.1.3 Growing prevalence of colorectal cancer 43
4.1.2 RESTRAINTS 43
4.1.2.1 Unfavorable healthcare reforms 43
4.1.2.2 Dearth of trained professionals 43
4.1.3 OPPORTUNITIES 44
4.1.3.1 Improving healthcare markets in emerging economies 44
4.1.3.2 Technological advancements and innovations in laparoscopic instruments 44
4.1.4 CHALLENGES 45
4.1.4.1 Regulatory hurdles and compliance complexity 45
4.2 UNMET NEEDS AND WHITE SPACES 45
4.2.1 UNMET NEEDS IN LAPAROSCOPIC INSTRUMENTS MARKET 45
4.2.2 WHITE SPACE OPPORTUNITIES 46
4.3 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 47
4.3.1 INTERCONNECTED MARKETS 48
4.3.2 CROSS-SECTOR OPPORTUNITIES MARKET 48
4.4 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 50

5 INDUSTRY TRENDS 51
5.1 PORTER’S FIVE FORCES ANALYSIS 51
5.1.1 INTENSITY OF COMPETITIVE RIVALRY 52
5.1.2 BARGAINING POWER OF SUPPLIERS 52
5.1.3 BARGAINING POWER OF BUYERS 52
5.1.4 THREAT OF SUBSTITUTES 53
5.1.5 THREAT OF NEW ENTRANTS 53
5.2 MACROECONOMIC OUTLOOK 53
5.2.1 INTRODUCTION 53
5.2.2 GDP TRENDS AND FORECAST 54
5.2.3 TRENDS IN MINIMALLY INVASIVE SURGERY INDUSTRY 55
5.2.4 TRENDS IN ENDOSCOPY EQUIPMENT INDUSTRY 56
5.3 SUPPLY CHAIN ANALYSIS 56
5.4 VALUE CHAIN ANALYSIS 57
5.5 ECOSYSTEM ANALYSIS 58
5.6 PRICING ANALYSIS 59
5.6.1 AVERAGE SELLING PRICE, BY KEY PLAYER (2025) 59
5.6.2 AVERAGE SELLING PRICE TREND, BY REGION (2023–2025) 59
5.7 TRADE DATA ANALYSIS 60
5.7.1 IMPORT DATA FOR LAPAROSCOPIC INSTRUMENTS PRODUCTS (HS CODE 901890) 60
5.7.2 EXPORT DATA FOR LAPAROSCOPIC INSTRUMENT PRODUCTS (HS CODE 901890) 60
5.8 KEY CONFERENCES AND EVENTS, 2026–2027 61
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 61
5.10 INVESTMENT AND FUNDING SCENARIO 62
5.11 CASE STUDY ANALYSIS 63
5.11.1 CASE STUDY 1: ETHICON’S ENSEAL X1 TISSUE SEALER TO TREAT UTERINE FIBROIDS 63
5.11.2 CASE STUDY 2: AIR QUALITY IMPROVEMENTS IN LAPAROSCOPIC DISINFECTION UNITS WITH AIRSTERIL PHOTO-CATALYTIC AIR PURIFIERS 63
5.11.3 CASE STUDY 3: UV-C DISINFECTION SYSTEMS IN OPERATING THEATERS TO REDUCE HOSPITAL-ACQUIRED INFECTIONS 64
5.12 IMPACT OF 2025 US TARIFFS—LAPAROSCOPIC INSTRUMENTS MARKET 64
5.12.1 INTRODUCTION 64
5.12.2 KEY TARIFF RATES 65
5.12.3 PRICE IMPACT ANALYSIS 65
5.12.4 IMPACT ON COUNTRIES/REGIONS 66
5.12.4.1 US 66
5.12.4.2 Europe 66
5.12.4.3 Asia Pacific 66
5.12.5 IMPACT ON END-USER INDUSTRIES 67

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 68
6.1 KEY EMERGING TECHNOLOGIES 68
6.1.1 HIGH-DEFINITION AND 4K IMAGING SYSTEMS 68
6.2 COMPLEMENTARY TECHNOLOGIES 68
6.2.1 SURGICAL NAVIGATION AND IMAGING SOFTWARE 68
6.3 ADJACENT TECHNOLOGIES 68
6.3.1 ROBOTIC SURGICAL PLATFORMS 68
6.4 TECHNOLOGY/PRODUCT ROADMAP 69
6.4.1 SHORT-TERM (2025–2027) PRODUCT REFINEMENT & COMMERCIAL EXPANSION 69
6.4.2 MID-TERM (2027–2030) | FUNCTIONAL INTEGRATION & BROADER ADOPTION 70
6.4.3 LONG-TERM (2030–2035+) | ADAPTIVE INSTRUMENTATION & SELECTIVE DISRUPTION 72
6.5 PATENT ANALYSIS 74
6.6 FUTURE APPLICATIONS OF LAPAROSCOPIC INSTRUMENTS 75
6.7 IMPACT OF AI/GEN AI ON LAPAROSCOPIC INSTRUMENTS MARKET 76
6.7.1 TOP USE CASES AND MARKET POTENTIAL 77
6.7.2 BEST PRACTICES IN LAPAROSCOPIC INSTRUMENTS 78
6.7.3 CASE STUDIES OF AI IMPLEMENTATION 78
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 79
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN LAPAROSCOPIC INSTRUMENTS MARKET 79

7 REGULATORY LANDSCAPE 80
7.1 REGIONAL REGULATIONS AND COMPLIANCE 80
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
7.1.1.1 North America: Regulatory Bodies, Government Agencies, and Other Organizations 80
7.1.1.2 Europe: Regulatory Bodies, Government Agencies, and Other Organizations 80
7.1.1.3 Asia Pacific: Regulatory Bodies, Government Agencies, and Other Organizations 81
7.1.2 REGULATORY FRAMEWORK 81
7.1.2.1 North America 81
7.1.2.1.1 US 81
7.1.2.1.2 Canada 82
7.1.2.2 Europe 83
7.1.2.3 Asia Pacific 83
7.1.2.3.1 Japan 83
7.1.2.3.2 China 84
7.1.2.3.3 India 85
7.1.2.4 Latin America 85
7.1.2.5 Middle East & Africa and GCC Countries 85
7.1.3 INDUSTRY STANDARDS 86
7.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 87

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 89
8.1 DECISION-MAKING PROCESS 89
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 89
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 89
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 91
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 92
8.5 MARKET PROFITABILITY 93
8.5.1 REVENUE POTENTIAL 93
8.5.2 COST DYNAMICS 94
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 94

9 LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT 96
9.1 INTRODUCTION 97
9.2 LAPAROSCOPES 97
9.2.1 VIDEO LAPAROSCOPES 99
9.2.1.1 Delivery of brighter and higher-quality images of mucosal surface to propel adoption 99
9.2.2 FIBER LAPAROSCOPES 101
9.2.2.1 Affordability and operational simplicity to aid adoption in resource-limited environments and basic diagnostic procedures 101
9.3 ENERGY DEVICES 103
9.3.1 INCREASING DEMAND FOR REUSABLE MONOPOLAR AND BIPOLAR COAGULATION ENERGY DEVICES TO BOOST MARKET GROWTH 103
9.4 CLOSURE DEVICES 104
9.4.1 TECHNOLOGICAL ADVANCEMENTS AND PRODUCT INNOVATIONS TO FUEL MARKET GROWTH 104
9.5 HAND INSTRUMENTS 106
9.5.1 RISING NUMBER OF GENERAL LAPAROSCOPIC SURGERIES TO FAVOR MARKET GROWTH 106
9.6 ACCESS DEVICES 108
9.6.1 ACCESS DEVICES TO CREATE AND MAINTAIN PORTS OF ENTRY FOR OTHER INSTRUMENTS 108
9.7 ACCESSORIES 110
9.7.1 INCREASING SURGICAL VOLUMES TO SUPPORT MARKET GROWTH 110
9.8 INSUFFLATORS 112
9.8.1 RISING NUMBER OF LAPAROSCOPIC SURGERIES TO BOOST DEMAND FOR CO2 INSUFFLATORS 112
9.9 SUCTION/IRRIGATION SYSTEMS 114
9.9.1 POPULARITY OF INTEGRATED FLUID MANAGEMENT SYSTEMS FOR LAPAROSCOPIC PROCEDURES TO DRIVE MARKET 114

10 LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE 116
10.1 INTRODUCTION 117
10.2 REUSABLE LAPAROSCOPIC INSTRUMENTS 117
10.2.1 HIGH DURABILITY, COST-EFFECTIVENESS, AND BETTER COMPATIBILITY TO FUEL MARKET GROWTH 117
10.3 DISPOSABLE LAPAROSCOPIC INSTRUMENTS 118
10.3.1 RISING EMPHASIS ON INFECTION PREVENTION AND INCREASING NUMBER OF OUTPATIENT PROCEDURES TO PROPEL MARKET 118

11 LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION 120
11.1 INTRODUCTION 121
11.2 GENERAL SURGERY 121
11.2.1 PREFERENCE FOR LAPAROSCOPIC TECHNIQUES IS INCREASING FOR APPENDECTOMY, CHOLECYSTECTOMY, AND HERNIA REPAIR 121
11.3 GYNECOLOGICAL SURGERY 123
11.3.1 INCREASING DEMAND FOR MINIMALLY INVASIVE GYNECOLOGICAL SURGERIES TO DRIVE MARKET 123
11.4 COLORECTAL SURGERY 124
11.4.1 INCREASING INCIDENCE OF COLORECTAL CANCER TO AID MARKET GROWTH 124
11.5 BARIATRIC SURGERY 126
11.5.1 GROWING PREVALENCE OF OBESITY TO AUGMENT MARKET GROWTH 126
11.6 UROLOGICAL SURGERY 128
11.6.1 INCREASING INCIDENCE OF CHRONIC UROLOGICAL DISEASES TO DRIVE MARKET 128
11.7 PEDIATRIC SURGERY 129
11.7.1 PREFERENCE FOR MINIMALLY INVASIVE TECHNIQUES IN TREATING CONGENITAL CONDITIONS IN CHILDREN TO BOOST MARKET GROWTH 129
11.8 OTHER APPLICATIONS 131

12 LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER 134
12.1 INTRODUCTION 135
12.2 HOSPITALS & CLINICS 135
12.2.1 HIGH INVESTMENTS FROM GOVERNMENT BODIES AND PRIVATE INVESTORS TO DRIVE MARKET 135
12.3 AMBULATORY SURGICAL CENTERS 137
12.3.1 INCREASED ADOPTION OF OUTPATIENT SURGERIES TO BOOST MARKET GROWTH 137
12.4 OTHER END USERS 139

13 LAPAROSCOPIC INSTRUMENTS MARKET, BY REGION 141
13.1 INTRODUCTION 142
13.2 NORTH AMERICA 142
13.2.1 US 145
13.2.1.1 US to dominate global laparoscopic instruments market during forecast period 145
13.2.2 CANADA 148
13.2.2.1 Rising incidence of chronic diseases among geriatric population to fuel market growth 148
13.3 EUROPE 151
13.3.1 GERMANY 154
13.3.1.1 High incidence of cancer and stroke to propel market growth 154
13.3.2 FRANCE 156
13.3.2.1 Favorable health insurance system and increased adoption of minimally invasive surgical procedures to boost market growth 156
13.3.3 UK 159
13.3.3.1 Implementation of National Bowel Cancer Screening Programme by NHS to support adoption of laparoscopy 159
13.3.4 ITALY 161
13.3.4.1 Rising prevalence of colorectal cancer to boost market growth 161
13.3.5 SPAIN 164
13.3.5.1 Superior reimbursement scenario to augment market growth 164
13.3.6 REST OF EUROPE 166
13.4 ASIA PACIFIC 168
13.4.1 JAPAN 171
13.4.1.1 Rapid growth in geriatric population and innovations in laparoscopic surgeries to fuel market growth 171
13.4.2 CHINA 174
13.4.2.1 Rising government healthcare spending to drive adoption of laparoscopic instruments 174
13.4.3 INDIA 176
13.4.3.1 Healthcare infrastructural improvements and implementation of favorable government initiatives to support market growth 176
13.4.4 AUSTRALIA 179
13.4.4.1 Increasing obesity rates and rising number of bariatric surgeries to aid market growth 179
13.4.5 SOUTH KOREA 181
13.4.5.1 High geriatric population and increased number of surgical procedures to propel market growth 181
13.4.6 REST OF ASIA PACIFIC 183
13.5 LATIN AMERICA 185
13.5.1 BRAZIL 188
13.5.1.1 High demand for advanced surgical technologies to spur adoption of laparoscopic instruments 188
13.5.2 MEXICO 190
13.5.2.1 Increasing incidence of lifestyle-related disorders to augment market growth 190
13.5.3 REST OF LATIN AMERICA 192
13.6 MIDDLE EAST & AFRICA 195
13.6.1 GCC COUNTRIES 198
13.6.1.1 Increasing incidence of lifestyle-related disorders and growing disposable income to favor market growth 198
13.6.2 REST OF MIDDLE EAST & AFRICA 200

14 COMPETITIVE LANDSCAPE 203
14.1 INTRODUCTION 203
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 203
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LAPAROSCOPIC INSTRUMENTS MARKET 203
14.3 REVENUE ANALYSIS, 2021–2025 205
14.4 MARKET SHARE ANALYSIS, 2025 206
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 208
14.5.1 STARS 208
14.5.2 EMERGING LEADERS 208
14.5.3 PERVASIVE PLAYERS 208
14.5.4 PARTICIPANTS 209
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 210
14.5.5.1 Company footprint 210
14.5.5.2 Region footprint 211
14.5.5.3 Product footprint 212
14.5.5.4 Usage footprint 213
14.5.5.5 Application footprint 214
14.5.5.6 End-user footprint 215
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 216
14.6.1 PROGRESSIVE COMPANIES 216
14.6.2 DYNAMIC COMPANIES 216
14.6.3 RESPONSIVE COMPANIES 216
14.6.4 STARTING BLOCKS 216
14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 218
14.7 COMPANY VALUATION AND FINANCIAL METRICS 219
14.7.1 FINANCIAL METRICS 219
14.7.2 COMPANY VALUATION 219
14.7.3 BRAND/PRODUCT COMPARISON 220
14.8 COMPETITIVE SCENARIO 220
14.8.1 PRODUCT LAUNCHES & APPROVALS 220
14.8.2 DEALS 221

15 COMPANY PROFILES 222
15.1 KEY PLAYERS 222
15.1.1 JOHNSON & JOHNSON 222
15.1.1.1 Business overview 222
15.1.1.2 Products offered 223
15.1.1.3 MnM view 224
15.1.1.3.1 Right to win 224
15.1.1.3.2 Strategic choices 225
15.1.1.3.3 Weaknesses & competitive threats 225
15.1.2 MEDTRONIC 226
15.1.2.1 Business overview 226
15.1.2.2 Products offered 227
15.1.2.3 Recent developments 229
15.1.2.3.1 Product launches 229
15.1.2.3.2 Deals 229
15.1.2.4 MnM view 229
15.1.2.4.1 Right to win 229
15.1.2.4.2 Strategic choices 230
15.1.2.4.3 Weaknesses & competitive threats 230
15.1.3 STRYKER 231
15.1.3.1 Business overview 231
15.1.3.2 Products offered 232
15.1.3.3 Recent developments 233
15.1.3.3.1 Product launches 233
15.1.3.3.2 Deals 233
15.1.3.3.3 Expansions 234
15.1.3.4 MnM view 234
15.1.3.4.1 Right to win 234
15.1.3.4.2 Strategic choices 234
15.1.3.4.3 Weaknesses & competitive threats 234
15.1.4 OLYMPUS CORPORATION 235
15.1.4.1 Business overview 235
15.1.4.2 Products offered 236
15.1.4.3 Recent developments 237
15.1.4.3.1 Product launches 237
15.1.4.3.2 Deals 238
15.1.4.4 MnM view 238
15.1.4.4.1 Right to win 238
15.1.4.4.2 Strategic choices 238
15.1.4.4.3 Weaknesses & competitive threats 238
15.1.5 APPLIED MEDICAL 239
15.1.5.1 Business overview 239
15.1.5.2 Products offered 239
15.1.5.3 Recent developments 241
15.1.5.3.1 Product launches & approvals 241
15.1.5.3.2 Deals 242
15.1.5.4 MnM view 242
15.1.5.4.1 Right to win 242
15.1.5.4.2 Strategic choices 242
15.1.5.4.3 Weaknesses & competitive threats 242
15.1.6 KARL STORZ SE & CO. KG 243
15.1.6.1 Business overview 243
15.1.6.2 Products offered 243
15.1.6.3 Recent developments 244
15.1.6.3.1 Deals 244
15.1.7 FUJIFILM HOLDINGS CORPORATION 245
15.1.7.1 Business overview 245
15.1.7.2 Products offered 246
15.1.8 HOYA CORPORATION 247
15.1.8.1 Business overview 247
15.1.8.2 Products offered 248
15.1.8.3 Recent developments 249
15.1.8.3.1 Deals 249
15.1.9 CONMED CORPORATION 250
15.1.9.1 Business overview 250
15.1.9.2 Products offered 251
15.1.10 COOK 253
15.1.10.1 Business overview 253
15.1.10.2 Products offered 253
15.1.11 B. BRAUN SE 255
15.1.11.1 Business overview 255
15.1.11.2 Products offered 256
15.1.12 VICTOR MEDICAL INSTRUMENTS CO., LTD. 258
15.1.12.1 Business overview 258
15.1.12.2 Products offered 258
15.1.13 ENDOMED SYSTEMS GMBH 259
15.1.13.1 Business overview 259
15.1.13.2 Products offered 259
15.1.14 SCHÖLLY FIBEROPTIC GMBH 261
15.1.14.1 Business overview 261
15.1.14.2 Products offered 261
15.1.15 BOSTON SCIENTIFIC CORPORATION 262
15.1.15.1 Business overview 262
15.1.15.2 Products offered 263
15.2 OTHER PLAYERS 264
15.2.1 BOWA MEDICAL 264
15.2.2 COOPER COMPANIES 265
15.2.3 ERBE 266
15.2.4 KANGJI MEDICAL 267
15.2.5 MINDRAY 268
15.2.6 TELEFLEX INCORPORATED 269
15.2.7 FORTIMEDIX SURGICAL 270
15.2.8 DANTSCHKE MEDIZINTECHNIK GMBH & CO. KG 271
15.2.9 MYELOTEC, INC. 272
15.2.10 RICHARD WOLF GMBH 272
15.2.11 ZHEJIANG GEYI MEDICAL INSTRUMENT CO., LTD. 273

16 RESEARCH METHODOLOGY 274
16.1 RESEARCH DATA 274
16.1.1 SECONDARY DATA 274
16.1.1.1 Key data from secondary sources 276
16.1.2 PRIMARY DATA 276
16.1.2.1 Key data from primary sources 277
16.1.2.2 Key industry insights 277
16.2 MARKET SIZE ESTIMATION 277
16.2.1 BOTTOM-UP APPROACH 278
16.2.2 TOP-DOWN APPROACH 278
16.2.3 BASE NUMBER ESTIMATION 278
16.3 MARKET FORECAST APPROACH 280
16.4 MARKET BREAKDOWN AND DATA TRIANGULATION 282
16.5 ASSUMPTIONS 282
16.5.1 MARKET SHARE ASSUMPTIONS 282
16.5.2 RESEARCH ASSUMPTIONS 283
16.6 FACTOR ANALYSIS 283
16.7 RISK ASSESSMENT 284
16.8 METHODOLOGY-RELATED LIMITATIONS 284
16.8.1 SCOPE-RELATED LIMITATIONS 284
16.8.2 METHODOLOGY-RELATED LIMITATIONS 284

17 APPENDIX 285
17.1 DISCUSSION GUIDE 285
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 289
17.3 CUSTOMIZATION OPTIONS 291
17.4 RELATED REPORTS 291
17.5 AUTHOR DETAILS 292

ページTOPに戻る

List of Tables/Graphs

FIGURE 1 LAPAROSCOPIC INSTRUMENTS MARKET: SEGMENTS CONSIDERED 29.
FIGURE 2 LAPAROSCOPIC INSTRUMENTS MARKET: YEARS CONSIDERED 30.
FIGURE 3 KEY INSIGHTS & MARKET HIGHLIGHTS 32.
FIGURE 4 GLOBAL LAPAROSCOPIC INSTRUMENTS MARKET, 2024–2031 33.
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN LAPAROSCOPIC INSTRUMENTS MARKET 33.
FIGURE 6 DISRUPTIVE TRENDS IMPACTING GROWTH OF LAPAROSCOPIC INSTRUMENTS MARKET 34.
FIGURE 7 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN LAPAROSCOPIC INSTRUMENTS MARKET, 2026 35.
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 36.
FIGURE 9 RISING NUMBER OF MINIMALLY INVASIVE SURGERIES AND ADVANCEMENTS IN LAPAROSCOPIC SYSTEMS TO DRIVE MARKET 37.
FIGURE 10 DISPOSABLE LAPAROSCOPES ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2025 38.
FIGURE 11 INDIA TO REGISTER THE HIGHEST GROWTH RATE DURING FORECAST PERIOD 39.
FIGURE 12 NORTH AMERICA TO CONTINUE TO DOMINATE MARKET DURING FORECAST PERIOD 40.
FIGURE 13 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES 40.
FIGURE 14 LAPAROSCOPIC INSTRUMENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41.
FIGURE 15 LAPAROSCOPIC INSTRUMENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 51.
FIGURE 16 LAPAROSCOPIC INSTRUMENTS MARKET SUPPLY CHAIN ANALYSIS 57.
FIGURE 17 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE 58.
FIGURE 18 LAPAROSCOPIC INSTRUMENTS MARKET: ECOSYSTEM ANALYSIS 58.
FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN LAPAROSCOPIC INSTRUMENTS MARKET 62.
FIGURE 20 INVESTMENT/VENTURE CAPITAL SCENARIO IN LAPAROSCOPIC INSTRUMENTS MARKET, 2020–2023 62.
FIGURE 21 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR LAPAROSCOPIC INSTRUMENTS MARKET (JANUARY 2016–SEPTEMBER 2026) 74.
FIGURE 22 TOP PATENT APPLICANT COUNTRIES FOR LAPAROSCOPIC INSTRUMENTS (JANUARY 2016–SEPTEMBER 2026) 75.
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 90.
FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 90.
FIGURE 25 NORTH AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET SNAPSHOT 143.
FIGURE 26 ASIA PACIFIC: LAPAROSCOPIC INSTRUMENTS MARKET SNAPSHOT 169.
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN LAPAROSCOPIC INSTRUMENTS MARKET (2021−2025) 205.
FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS IN LAPAROSCOPIC INSTRUMENTS MARKET (2025) 206.
FIGURE 29 LAPAROSCOPIC INSTRUMENTS MARKET: COMPANY EVALUATION MATRIX.
(KEY PLAYERS), 2025 209.
FIGURE 30 LAPAROSCOPIC INSTRUMENTS MARKET: COMPANY FOOTPRINT 210.
FIGURE 31 LAPAROSCOPIC INSTRUMENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 217.
FIGURE 32 EV/EBITDA OF KEY VENDORS 219.
FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF.
KEY VENDORS 219.
FIGURE 34 LAPAROSCOPIC INSTRUMENTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 220.
FIGURE 35 JOHNSON & JOHNSON: COMPANY SNAPSHOT 223.
FIGURE 36 MEDTRONIC: COMPANY SNAPSHOT 227.
FIGURE 37 STRYKER: COMPANY SNAPSHOT 232.
FIGURE 38 OLYMPUS CORPORATION: COMPANY SNAPSHOT 236.
FIGURE 39 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT 246.
FIGURE 40 HOYA CORPORATION: COMPANY SNAPSHOT 248.
FIGURE 41 CONMED CORPORATION: COMPANY SNAPSHOT 251.
FIGURE 42 B. BRAUN SE: COMPANY SNAPSHOT 256.
FIGURE 43 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 263.
FIGURE 44 RESEARCH DESIGN 274.
FIGURE 45 PRIMARY SOURCES 276.
FIGURE 46 BOTTOM-UP APPROACH 278.
FIGURE 47 TOP-DOWN APPROACH 278.
FIGURE 48 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 279.
FIGURE 49 REVENUE SHARE ANALYSIS ILLUSTRATION: JOHNSON & JOHNSON 279.
FIGURE 50 SUPPLY-SIDE MARKET ESTIMATION: LAPAROSCOPIC INSTRUMENTS.
MARKET (2025) 280.
FIGURE 51 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 281.
FIGURE 52 MARKET DATA TRIANGULATION METHODOLOGY 282.
TABLE 1 LAPAROSCOPIC INSTRUMENTS MARKET: INCLUSIONS AND EXCLUSIONS 29.
TABLE 2 LAPAROSCOPIC INSTRUMENTS MARKET: CURRENT UNMET NEEDS 45.
TABLE 3 LAPAROSCOPIC INSTRUMENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 51.
TABLE 4 GDP PERCENTAGE CHANGE, BY COUNTRY, 2021–2030 54.
TABLE 5 AVERAGE SELLING PRICE OF LAPAROSCOPIC INSTRUMENTS, BY KEY PLAYER, 2025 (USD) 59.
TABLE 6 AVERAGE PRICING TREND OF LAPAROSCOPIC INSTRUMENTS, BY REGION,.
2023–2025 (USD) 59.
TABLE 7 IMPORT DATA FOR LAPAROSCOPIC INSTRUMENTS PRODUCTS (HS CODE 901890), BY COUNTRY, 2021–2025 (USD THOUSAND) 60.
TABLE 8 EXPORT DATA FOR LAPAROSCOPIC INSTRUMENTS PRODUCTS (HS CODE 901890), BY COUNTRY, 2021–2025 (USD THOUSAND) 60.
TABLE 9 LAPAROSCOPIC INSTRUMENTS MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS (2026–2027) 61.
TABLE 10 US ADJUSTED RECIPROCAL TARIFF RATES 65.
TABLE 11 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR LAPAROSCOPIC INSTRUMENTS MARKET 65.
TABLE 12 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 82.
TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 82.
TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 83.
TABLE 15 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES IN JAPAN 84.
TABLE 16 NMPA MEDICAL DEVICES CLASSIFICATION 85.
TABLE 17 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LAPAROSCOPY,.
BY COUNTRY/REGION 86.
TABLE 18 GLOBAL STANDARDS IN LAPAROSCOPIC INSTRUMENTS MARKET 86.
TABLE 19 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN LAPAROSCOPIC INSTRUMENTS MARKET 87.
TABLE 20 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 90.
TABLE 21 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 91.
TABLE 22 LAPAROSCOPIC INSTRUMENTS MARKET: UNMET NEEDS AND END-USER EXPECTATIONS 92.
TABLE 23 LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 97.
TABLE 24 KEY LAPAROSCOPES AVAILABLE IN MARKET 98.
TABLE 25 LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 98.
TABLE 26 LAPAROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 99.
TABLE 27 KEY VIDEO LAPAROSCOPES AVAILABLE IN MARKET 100.
TABLE 28 VIDEO LAPAROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 100.
TABLE 29 KEY FIBER LAPAROSCOPES AVAILABLE IN MARKET 101.
TABLE 30 FIBER LAPAROSCOPES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 102.
TABLE 31 KEY ENERGY DEVICES AVAILABLE IN MARKET 103.
TABLE 32 ENERGY DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 104.
TABLE 33 KEY CLOSURE DEVICES AVAILABLE IN MARKET 105.
TABLE 34 CLOSURE DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 105.
TABLE 35 KEY HAND INSTRUMENTS AVAILABLE IN MARKET 107.
TABLE 36 HAND INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 108.
TABLE 37 KEY ACCESS DEVICES AVAILABLE IN MARKET 109.
TABLE 38 ACCESS DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 109.
TABLE 39 ACCESSORIES AND THEIR FUNCTIONALITIES IN LAPAROSCOPIC INSTRUMENTS MARKET 110.
TABLE 40 KEY ACCESSORIES AVAILABLE IN MARKET 110.
TABLE 41 ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 112.
TABLE 42 KEY INSUFFLATORS AVAILABLE IN MARKET 113.
TABLE 43 INSUFFLATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 113.
TABLE 44 KEY SUCTION/IRRIGATION SYSTEMS AVAILABLE IN MARKET 114.
TABLE 45 SUCTION/IRRIGATION SYSTEMS MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 115.
TABLE 46 LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE, 2024–2031 (USD MILLION) 117.
TABLE 47 REUSABLE LAPAROSCOPIC INSTRUMENTS MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 118.
TABLE 48 DISPOSABLE LAPAROSCOPIC INSTRUMENTS MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 119.
TABLE 49 LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 121.
TABLE 50 EVOLUTION OF LAPAROSCOPY FOR COMMON PROCEDURES IN GENERAL SURGERY 122.
TABLE 51 LAPAROSCOPIC INSTRUMENTS MARKET FOR GENERAL SURGERY, BY COUNTRY, 2024–2031 (USD MILLION) 122.
TABLE 52 LAPAROSCOPIC INSTRUMENTS MARKET FOR GYNECOLOGICAL SURGERY,.
BY COUNTRY, 2024–2031 (USD MILLION) 124.
TABLE 53 ESTIMATED NUMBER OF NEW CASES OF COLON, RECTAL, AND ANAL CANCER,.
BY REGION, 2020 VS. 2040 (THOUSAND) 125.
TABLE 54 LAPAROSCOPIC INSTRUMENTS MARKET FOR COLORECTAL SURGERY,.
BY COUNTRY, 2024–2031 (USD MILLION) 126.
TABLE 55 LAPAROSCOPIC INSTRUMENTS MARKET FOR BARIATRIC SURGERY, BY COUNTRY, 2024–2031 (USD MILLION) 127.
TABLE 56 LAPAROSCOPIC INSTRUMENTS MARKET FOR UROLOGICAL SURGERY,.
BY COUNTRY, 2024–2031 (USD MILLION) 129.
TABLE 57 LAPAROSCOPIC INSTRUMENTS MARKET FOR PEDIATRIC SURGERY, BY COUNTRY, 2024–2031 (USD MILLION) 131.
TABLE 58 LAPAROSCOPIC INSTRUMENTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 133.
TABLE 59 LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 135.
TABLE 60 LAPAROSCOPIC INSTRUMENTS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 136.
TABLE 61 MEDICARE REIMBURSEMENT RATES OF LAPAROSCOPIC PROCEDURES IN ASCS AND HOSPITALS, 2021 138.
TABLE 62 LAPAROSCOPIC INSTRUMENTS MARKET FOR ASCS, BY COUNTRY,.
2024–2031 (USD MILLION) 139.
TABLE 63 LAPAROSCOPIC INSTRUMENTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 140.
TABLE 64 LAPAROSCOPIC INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 142.
TABLE 65 NORTH AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 143.
TABLE 66 NORTH AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 144.
TABLE 67 NORTH AMERICA: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 144.
TABLE 68 NORTH AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 144.
TABLE 69 NORTH AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 145.
TABLE 70 NORTH AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 145.
TABLE 71 US: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 146.
TABLE 72 US: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 147.
TABLE 73 US: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 147.
TABLE 74 US: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 147.
TABLE 75 US: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 148.
TABLE 76 CANADA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 149.
TABLE 77 CANADA: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 149.
TABLE 78 CANADA: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 150.
TABLE 79 CANADA: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 150.
TABLE 80 CANADA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 150.
TABLE 81 EUROPE: LAPAROSCOPIC INSTRUMENTS MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 152.
TABLE 82 EUROPE: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 152.
TABLE 83 EUROPE: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 153.
TABLE 84 EUROPE: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 153.
TABLE 85 EUROPE: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 153.
TABLE 86 EUROPE: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 154.
TABLE 87 GERMANY: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 155.
TABLE 88 GERMANY: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 155.
TABLE 89 GERMANY: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 155.
TABLE 90 GERMANY: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 156.
TABLE 91 GERMANY: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 156.
TABLE 92 FRANCE: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 157.
TABLE 93 FRANCE: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 158.
TABLE 94 FRANCE: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 158.
TABLE 95 FRANCE: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 158.
TABLE 96 FRANCE: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 159.
TABLE 97 UK: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 160.
TABLE 98 UK: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 160.
TABLE 99 UK: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 160.
TABLE 100 UK: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 161.
TABLE 101 UK: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 161.
TABLE 102 ITALY: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 162.
TABLE 103 ITALY: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 162.
TABLE 104 ITALY: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 163.
TABLE 105 ITALY: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 163.
TABLE 106 ITALY: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 163.
TABLE 107 SPAIN: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 164.
TABLE 108 SPAIN: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 165.
TABLE 109 SPAIN: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 165.
TABLE 110 SPAIN: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 165.
TABLE 111 SPAIN: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 166.
TABLE 112 REST OF EUROPE: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 167.
TABLE 113 REST OF EUROPE: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 167.
TABLE 114 REST OF EUROPE: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 167.
TABLE 115 REST OF EUROPE: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 168.
TABLE 116 REST OF EUROPE: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 168.
TABLE 117 ASIA PACIFIC: LAPAROSCOPIC INSTRUMENTS MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 169.
TABLE 118 ASIA PACIFIC: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 170.
TABLE 119 ASIA PACIFIC: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 170.
TABLE 120 ASIA PACIFIC: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 170.
TABLE 121 ASIA PACIFIC: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 171.
TABLE 122 ASIA PACIFIC: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 171.
TABLE 123 JAPAN: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 172.
TABLE 124 JAPAN: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 172.
TABLE 125 JAPAN: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 173.
TABLE 126 JAPAN: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 173.
TABLE 127 JAPAN: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 173.
TABLE 128 CHINA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 175.
TABLE 129 CHINA: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 175.
TABLE 130 CHINA: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 175.
TABLE 131 CHINA: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 176.
TABLE 132 CHINA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 176.
TABLE 133 INDIA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 177.
TABLE 134 INDIA: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 177.
TABLE 135 INDIA: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 178.
TABLE 136 INDIA: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 178.
TABLE 137 INDIA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 178.
TABLE 138 AUSTRALIA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 179.
TABLE 139 AUSTRALIA: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 179.
TABLE 140 AUSTRALIA: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 180.
TABLE 141 AUSTRALIA: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 180.
TABLE 142 AUSTRALIA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 180.
TABLE 143 SOUTH KOREA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 181.
TABLE 144 SOUTH KOREA: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 182.
TABLE 145 SOUTH KOREA: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 182.
TABLE 146 SOUTH KOREA: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 182.
TABLE 147 SOUTH KOREA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 183.
TABLE 148 REST OF ASIA PACIFIC: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 184.
TABLE 149 REST OF ASIA PACIFIC: LAPAROSCOPES MARKET, BY TYPE,.
2024–2031 (USD MILLION) 184.
TABLE 150 REST OF ASIA PACIFIC: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE, 2024–2031 (USD MILLION) 184.
TABLE 151 REST OF ASIA PACIFIC: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 185.
TABLE 152 REST OF ASIA PACIFIC: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 185.
TABLE 153 LATIN AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 186.
TABLE 154 LATIN AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 186.
TABLE 155 LATIN AMERICA: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 186.
TABLE 156 LATIN AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 187.
TABLE 157 LATIN AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 187.
TABLE 158 LATIN AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 187.
TABLE 159 BRAZIL: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 188.
TABLE 160 BRAZIL: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 189.
TABLE 161 BRAZIL: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 189.
TABLE 162 BRAZIL: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 189.
TABLE 163 BRAZIL: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 190.
TABLE 164 MEXICO: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 191.
TABLE 165 MEXICO: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 191.
TABLE 166 MEXICO: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 191.
TABLE 167 MEXICO: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 192.
TABLE 168 MEXICO: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 192.
TABLE 169 REST OF LATIN AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 193.
TABLE 170 REST OF LATIN AMERICA: LAPAROSCOPES MARKET, BY TYPE,.
2024–2031 (USD MILLION) 193.
TABLE 171 REST OF LATIN AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE, 2024–2031 (USD MILLION) 194.
TABLE 172 REST OF LATIN AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET,.
BY APPLICATION, 2024–2031 (USD MILLION) 194.
TABLE 173 REST OF LATIN AMERICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 194.
TABLE 174 MIDDLE EAST & AFRICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 196.
TABLE 175 MIDDLE EAST & AFRICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 196.
TABLE 176 MIDDLE EAST & AFRICA: LAPAROSCOPES MARKET, BY TYPE,.
2024–2031 (USD MILLION) 196.
TABLE 177 MIDDLE EAST & AFRICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE, 2024–2031 (USD MILLION) 197.
TABLE 178 MIDDLE EAST & AFRICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 197.
TABLE 179 MIDDLE EAST & AFRICA: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER, 2024–2031 (USD MILLION) 197.
TABLE 180 GCC COUNTRIES: LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT,.
2024–2031 (USD MILLION) 198.
TABLE 181 GCC COUNTRIES: LAPAROSCOPES MARKET, BY TYPE, 2024–2031 (USD MILLION) 199.
TABLE 182 GCC COUNTRIES: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE,.
2024–2031 (USD MILLION) 199.
TABLE 183 GCC COUNTRIES: LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 199.
TABLE 184 GCC COUNTRIES: LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER,.
2024–2031 (USD MILLION) 200.
TABLE 185 REST OF MIDDLE EAST & AFRICA: LAPAROSCOPIC INSTRUMENTS MARKET,.
BY PRODUCT, 2024–2031 (USD MILLION) 201.
TABLE 186 REST OF MIDDLE EAST & AFRICA: LAPAROSCOPES MARKET, BY TYPE,.
2024–2031 (USD MILLION) 201.
TABLE 187 REST OF MIDDLE EAST & AFRICA: LAPAROSCOPIC INSTRUMENTS MARKET,.
BY USAGE, 2024–2031 (USD MILLION) 201.
TABLE 188 REST OF MIDDLE EAST & AFRICA: LAPAROSCOPIC INSTRUMENTS MARKET,.
BY APPLICATION, 2024–2031 (USD MILLION) 202.
TABLE 189 REST OF MIDDLE EAST & AFRICA: LAPAROSCOPIC INSTRUMENTS MARKET,.
BY END USER, 2024–2031 (USD MILLION) 202.
TABLE 190 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN LAPAROSCOPIC INSTRUMENTS MARKET 203.
TABLE 191 LAPAROSCOPIC INSTRUMENTS MARKET: DEGREE OF COMPETITION 206.
TABLE 192 LAPAROSCOPIC INSTRUMENTS MARKET: REGION FOOTPRINT 211.
TABLE 193 LAPAROSCOPIC INSTRUMENTS MARKET: PRODUCT FOOTPRINT 212.
TABLE 194 LAPAROSCOPIC INSTRUMENTS MARKET: USAGE FOOTPRINT 213.
TABLE 195 LAPAROSCOPIC INSTRUMENTS MARKET: APPLICATION FOOTPRINT 214.
TABLE 196 LAPAROSCOPIC INSTRUMENTS MARKET: END-USER FOOTPRINT 215.
TABLE 197 LAPAROSCOPIC INSTRUMENTS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 218.
TABLE 198 LAPAROSCOPIC INSTRUMENTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 218.
TABLE 199 LAPAROSCOPIC INSTRUMENTS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–AUGUST 2026 220.
TABLE 200 LAPAROSCOPIC INSTRUMENTS MARKET: DEALS, JANUARY 2023–AUGUST 2026 221.
TABLE 201 JOHNSON & JOHNSON: COMPANY OVERVIEW 222.
TABLE 202 JOHNSON & JOHNSON: PRODUCTS OFFERED 223.
TABLE 203 MEDTRONIC: COMPANY OVERVIEW 226.
TABLE 204 MEDTRONIC: PRODUCTS OFFERED 227.
TABLE 205 MEDTRONIC: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2025 229.
TABLE 206 MEDTRONIC: DEALS, JANUARY 2023–SEPTEMBER 2025 229.
TABLE 207 STRYKER: COMPANY OVERVIEW 231.
TABLE 208 STRYKER: PRODUCTS OFFERED 232.
TABLE 209 STRYKER: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2025 233.
TABLE 210 STRYKER: DEALS, JANUARY 2023–SEPTEMBER 2025 233.
TABLE 211 STRYKER: EXPANSIONS, JANUARY 2023–SEPTEMBER 2025 234.
TABLE 212 OLYMPUS CORPORATION: COMPANY OVERVIEW 235.
TABLE 213 OLYMPUS CORPORATION: PRODUCTS OFFERED 236.
TABLE 214 OLYMPUS CORPORATION: PRODUCT LAUNCHES,.
JANUARY 2023–SEPTEMBER 2025 237.
TABLE 215 OLYMPUS CORPORATION: DEALS, JANUARY 2023–SEPTEMBER 2025 238.
TABLE 216 APPLIED MEDICAL: COMPANY OVERVIEW 239.
TABLE 217 APPLIED MEDICAL: PRODUCTS OFFERED 239.
TABLE 218 APPLIED MEDICAL: PRODUCT LAUNCHES & APPROVALS,.
JANUARY 2023–SEPTEMBER 2026 241.
TABLE 219 APPLIED MEDICAL: DEALS, JANUARY 2023–SEPTEMBER 2026 242.
TABLE 220 KARL STORZ SE & CO. KG: COMPANY OVERVIEW 243.
TABLE 221 KARL STORZ SE & CO. KG: PRODUCTS OFFERED 243.
TABLE 222 KARL STORZ SE & CO. KG: DEALS, JANUARY 2023–SEPTEMBER 2025 244.
TABLE 223 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 245.
TABLE 224 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED 246.
TABLE 225 HOYA CORPORATION: COMPANY OVERVIEW 247.
TABLE 226 HOYA CORPORATION: PRODUCTS OFFERED 248.
TABLE 227 HOYA CORPORATION: DEALS, JANUARY 2023–SEPTEMBER 2026 249.
TABLE 228 CONMED CORPORATION: COMPANY OVERVIEW 250.
TABLE 229 CONMED CORPORATION: PRODUCTS OFFERED 251.
TABLE 230 COOK: COMPANY OVERVIEW 253.
TABLE 231 COOK: PRODUCTS OFFERED 253.
TABLE 232 B. BRAUN SE: COMPANY OVERVIEW 255.
TABLE 233 B. BRAUN SE: PRODUCTS OFFERED 256.
TABLE 234 VICTOR MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW 258.
TABLE 235 VICTOR MEDICAL INSTRUMENTS CO., LTD.: PRODUCTS OFFERED 258.
TABLE 236 ENDOMED SYSTEMS GMBH: COMPANY OVERVIEW 259.
TABLE 237 ENDOMED SYSTEMS GMBH: PRODUCTS OFFERED 259.
TABLE 238 SCHÖLLY FIBEROPTIC GMBH: COMPANY OVERVIEW 261.
TABLE 239 SCHÖLLY FIBEROPTIC GMBH: PRODUCTS OFFERED 261.
TABLE 240 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 262.
TABLE 241 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 263.
TABLE 242 BOWA MEDICAL: COMPANY OVERVIEW 264.
TABLE 243 COOPER COMPANIES: COMPANY OVERVIEW 265.
TABLE 244 ERBE: COMPANY OVERVIEW 266.
TABLE 245 KANGJI MEDICAL: COMPANY OVERVIEW 267.
TABLE 246 MINDRAY: COMPANY OVERVIEW 268.
TABLE 247 TELEFLEX INCORPORATED: COMPANY OVERVIEW 269.
TABLE 248 FORTIMEDIX SURGICAL: COMPANY OVERVIEW 270.
TABLE 249 DANTSCHKE MEDIZINTECHNIK GMBH & CO. KG: COMPANY OVERVIEW 271.
TABLE 250 MYELOTEC, INC.: COMPANY OVERVIEW 272.
TABLE 251 RICHARD WOLF GMBH: COMPANY OVERVIEW 272.
TABLE 252 ZHEJIANG GEYI MEDICAL INSTRUMENT CO., LTD.: COMPANY OVERVIEW 273.
TABLE 253 RISK ASSESSMENT: LAPAROSCOPIC INSTRUMENTS MARKET 284.